May 21, 2021
Member/Center Highlights
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
Case Comprehensive Cancer Center and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
Case Comprehensive Cancer Center, a partnership of Case Western Reserve University, University Hospitals and Cleveland Clinic, has joined with 71 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to issue a joint statement urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

Dramatic drops in annual well visits and immunizations during the COVID-19 pandemic have caused a significant vaccination gap and lag in vital preventive services among U.S. children and adolescents—especially for the HPV vaccine.
Crain's Cleveland Business' Notables in Health Care: Salata, Markowitz, Chak and Willis
The Case Comprehensive Cancer Center extends congratulations to Robert Salata, MD, Sanford Markowitz, MD, PhD, Amitabh Chak, MD and Joseph Willis, MD, all highlighted by Crain's Cleveland Business in research and innovation category of the Crain's 2021 Notables in Health Care.

Dr. Salata, the STERIS Chair of Excellence in Medicine, was principal investigator for the Pfizer/BioNTech global vaccine study of BNT162b2 against COVID-19. He is a member of the Case CCC's Population and Cancer Prevention Program.

Drs. Markowitz, Chak and Willis are behind a new easily performed, minimally invasive and accurate biomarker test that could change outcomes for patients around the world. All are members of the Case GI Specialized Program of Research Excellence (Case GI SPORE).
Welcome, 2021 CanSUR Scholars!
Following a record-breaking application cycle, the Case Comprehensive Cancer Center Office of Cancer Training and Education is proud to announce the 32 scholars selected for the 2021 Cancer-focused Summer Undergraduate Research Program, CanSUR! The program kicks off June 1.
CWRU and Cleveland Clinic find COVID-19 variants may offer clues in predicting patient outcomes as virus evolves
From The Daily: A multidisciplinary team of scientists at Case Western Reserve University and Cleveland Clinic used genomic sequencing to track SARS-CoV-2 as it mutated in Northeast Ohio from March 11 to April 22, 2020. The research findings, published in JAMA Network Open, demonstrated that initial strains and subgroups of virus strains (called clades), seen during this time period, were associated with higher mortality while newer variants were associated with lower hospitalizations and deaths.

This research collaborative, led by Frank Esper, MD, a pediatric infectious disease physician at Cleveland Clinic Children’s, included experts in cancer genomics, computer and data sciences, neurology and pathology. Brian Rubin, MD, PhD, chair of Cleveland Clinic’s Robert J. Tomsich Pathology and Laboratory Medicine Institute, and Jing Li, PhD, the Leonard Case Jr. Professor in Case Western Reserve University’s Department of Computer and Data Sciences, were co-senior authors on the study. Dr. Rubin is a member of the Case Comprehensive Cancer Center.
Apply by June 3 for the Clinical Oncology Research Career Development Program
The purpose of the Clinical Oncology Research Career Development Program (CORP) is to provide interdisciplinary training in clinical and translational oncology research for clinical oncology junior faculty physicians who are interested in pursuing academic research careers as physician-scientists. This training addresses the need for clinician investigators to translate fundamental cancer research discoveries into medical care of cancer patients. Eligible candidates are physicians (MD, DO or MD/PhD) with a clinical training background in one of a number of oncology disciplines, including medical, surgical, pediatric, dermatological, gynecological and radiation oncology.
Trainees: Mark your calendars for the Bench to Bedside Retreat June 9
The 2021 Bench to Bedside Retreat will be held virtually Wednesday, June 9 at 12 pm ET and feature a keynote address from renowned immuno-oncology and genomics expert Timothy Chan, MD, PhD.
EXTENDED: Abstract Deadline for Annual Scientific Retreat
All students, postdocs and fellows conducting cancer research are invited to submit abstracts for two opportunities to present their research during the Case Comprehensive Cancer Center Annual Scientific Retreat: 1) poster presentation and 2) oral presentation. Cancer Center leadership will review abstracts based on the relationship to cancer, novelty, significance of findings and clarity.

Abstracts must be submitted by TODAY, Friday, May 21 at 5pm. 
What's Coming Up
Mark Your Calendar
Register Today for the Annual Scientific Retreat
July 22-23, 2021 | Virtual
The 2021 Annual Scientific Retreat for members and trainees is scheduled for July 22-23! As you may know, this is one of the few times a year our entire center is able to enjoy the company of one another and collaborate.

This year's virtual retreat features an expanded agenda that mirrors our prior in-person retreats, highlighting research across each of our scientific programs.

The retreat will begin Thursday with an address from Director Stan Gerson, MD, followed by TED-style Talks from Diana Bilimoria, PhD, Daniel E. Spratt, MD, and Serpil Erzurum, MD. Registration for the retreat is now open and trainees are encouraged to submit abstracts by Friday, May 14, 2021.
Zihai Li
Zihai Li, MD, PhD will present the retreat keynote on Friday, July 23. Dr. Li is the founding director of the Pelotonia Institute for Immuno-Oncology and the Klotz Chair in Cancer Research at The Ohio State University.
Register today for VeloSano 8!
Bike to Cure Weekend | September 10-12, 2021
We are looking ahead with optimism to VeloSano 8 with a goal of providing opportunities to reunite our VeloSano community in a variety of safe and meaningful ways!

VeloSano is offering options for anyone to participate in any way they are most comfortable - whether riding with us during "Bike to Cure" weekend September 10-12; riding virtually, or by choosing your own activity to participate anytime, anywhere as a Virtual Fundraiser.

The Case Comprehensive Cancer Center, Team Case CCC, will be joining VeloSano again this year and providing complimentary registration and jerseys for its riders. Please contact team captains Caroline El Sanadi or Mary Wright for the registration waiver or code with any questions!
Save the Date: Great Lakes Breast Cancer Symposium
October 25-26, 2021 | Virtual
Save the date for the Great Lakes Breast Cancer Symposium, to be held virtually October 25-26, 2021!

This annual symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.

Though this event is happening virtually, attendees will experience the conference using Whova, our official web-based conference app, to view presentations and ask questions in real-time, as well as network with others behind the scenes.
Helen Piwnica Worms
Helen Piwnica-Worms, PhD, will deliver a keynote at the symposium. Dr. Piwnica-Worms is Professor, Department of Experimental Radiation Oncology, Division of Radiation Oncology and Senator AM Aiken Jr. Distinguished Chair at University of Texas MD Anderson Cancer Center.

Registration and call for abstracts for this symposium will open June 2021.
Additional Upcoming Events
2021 ASCO Annual Meeting 
June 4-8, 2021 | Virtual
The 2021 ASCO Annual Meeting, held online, will feature a dynamic program of educational and scientific sessions, showcasing what is possible when the cancer care community comes together to advance cancer research, treatment, and patient care.

Tune in to a scheduled broadcast experience from June 4-8, featuring 48 high-impact sessions with real-time engagement, live Q&A, and unparalleled learning. Also available beginning June 4, access on-demand content and view presentations from 175 sessions that align with your interests and expertise, featuring presentations from poster and poster discussion sessions, clinical science symposia and dynamic education sessions.
2021 Race for the Place
June 6, 2021 | Virtual
Race for the Place in support of The Gathering Place, takes place the first Sunday in June on National Cancer Survivors Day. The Race, a 5K and 1 Mile walk, is a wonderful celebration of cancer survivors and an opportunity to raise money to support the free programs and services provided at The Gathering Place to help children, teens, adults, individuals, families and friends cope while on the cancer journey.

Registration is now open!
NCCN Policy Summit: Defining the "New Normal"
June 15, 2021 | Virtual
Registration is now open for the next National Comprehensive Cancer Network (NCCN) policy summit: Defining the "New Normal" - 2021 and the State of Cancer Care in America Following 2020, held virtually Tuesday, June 15, 2021.

This FREE online program will explore how national health and sociopolitical events in 2020 will impact future cancer care delivery in the United States. Convening a group of diverse speakers and panelists, the virtual summit will discuss the influence of watershed events including the COVID-19 pandemic, post-election landscape, and national conversations of racial inequity on cancer care. Learn more about upcoming NCCN summits.
AACI Clinical Research Innovation 13th Annual Meeting
July 13-15, 2021 | Virtual
Registration is now open for the 13th Annual AACI CRI Meeting, Adapting Clinical Trials Offices for 2021 and Beyond which will be held virtually July 13-15. The program will provide panel discussions with content experts and breakout sessions for our members and abstract winners and runners-up will be acknowledged in poster sessions.

More information, including the program and registration, is now available on the CRI meeting website.
Funding Opportunities
With the generous support from VeloSano Bike to Cure 2020, the Case Comprehensive Cancer Center (Case CCC) is providing seed funding for innovative and impactful proposals that will generate key data for larger, nationally competitive multi-investigator/team grants (MPI R01, P01, U01, SPORE, etc.). The Case CCC has recently undertaken a reorientation of its scientific programs, and this award will provide funds for each of our six scientific programs. Program Leaders will select the award aligned to their program, and therefore will not serve as project PI. Projects must be focused on the establishment or support of a collaborative effort by a team of 2 or more independent investigators from the case Case CCC research program. The goal is to submit a federal team science grant application.
CDMRP logo
The Department of Defense and its Congressionally Directed Medical Research Programs (CDMRP) have announced program details and application instructions for the following FY2021 programs:

  • New! Melanoma Academy Leadership Award
  • New! Melanoma Academy Scholarship Award
  • Mid-Career Accelerator Award
  • Idea Award
  • Team Science Award
  • Translational Research Award

  • Idea Development Award
  • Idea Development Award – Early-Career Investigator Partnering PI Option
  • Translational Research Partnership Award

  • Concept Award
  • Idea Development Award
  • Resource and Community Development Award
Each year, the Children's Leukemia Research Association Medical Advisory Committee reviews submitted research proposals from doctors nationwide to fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for the disease. Any doctor in the United States at the PhD or MD level who is involved in research toward finding the causes and cure for leukemia may apply.
In The News
Newswise - May 12, 2021
“This is no small thing—this is an important next step in making AI useable for clinicians someday, and it’s one of things we have to address head on,” explained Anant Madabhushi, PhD, director of CWRU’s Center for Computational Imaging and Personalized Diagnostics and member, Case CCC.
OncLive - May 14, 2021
University Hospitals' Paolo Caimi, MD discusses the FDA approval of loncastuximab tesirine (Zynlonta) in relapsed/refractory large B-cell lymphoma (LBCL). Dr. Caimi is a member of the Case CCC's Immune Oncology Program.
From The NIH
Weekly NIH Funding Opportunities and Notices
COVID-19 Funding Opportunities and Notices
Have something to share?
Use the button below to submit all your news, publications, events, announcements, lab openings and communications requests to the Case CCC Marketing and Communications team! We are here to help.